Fasting reshapes tissue-specific niches to improve NK cell-mediated anti-tumor immunity.

NK cells anti-tumor responses fasting immunometabolism innate immunity metabolism

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
12 Jun 2024
Historique:
received: 15 06 2023
revised: 19 04 2024
accepted: 22 05 2024
medline: 16 6 2024
pubmed: 16 6 2024
entrez: 15 6 2024
Statut: aheadofprint

Résumé

Fasting is associated with improved outcomes in cancer. Here, we investigated the impact of fasting on natural killer (NK) cell anti-tumor immunity. Cyclic fasting improved immunity against solid and metastatic tumors in an NK cell-dependent manner. During fasting, NK cells underwent redistribution from peripheral tissues to the bone marrow (BM). In humans, fasting also reduced circulating NK cell numbers. NK cells in the spleen of fasted mice were metabolically rewired by elevated concentrations of fatty acids and glucocorticoids, augmenting fatty acid metabolism via increased expression of the enzyme CPT1A, and Cpt1a deletion impaired NK cell survival and function in this setting. In parallel, redistribution of NK cells to the BM during fasting required the trafficking mediators S1PR5 and CXCR4. These cells were primed by an increased pool of interleukin (IL)-12-expressing BM myeloid cells, which improved IFN-γ production. Our findings identify a link between dietary restriction and optimized innate immune responses, with the potential to enhance immunotherapy strategies.

Identifiants

pubmed: 38878769
pii: S1074-7613(24)00275-9
doi: 10.1016/j.immuni.2024.05.021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Rebecca B Delconte (RB)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: delcontr@mskcc.org.

Mark Owyong (M)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Medical College, New York, NY 10065, USA.

Endi K Santosa (EK)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Medical College, New York, NY 10065, USA.

Katja Srpan (K)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Sam Sheppard (S)

Department of Life Sciences, Imperial College London, London, UK.

Tomi J McGuire (TJ)

Immunology and Microbial Pathogenesis Program, Weill Cornell Medical College, New York, NY 10065, USA.

Aamna Abbasi (A)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Carlos Diaz-Salazar (C)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Jerold Chun (J)

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.

Inez Rogatsky (I)

Immunology and Microbial Pathogenesis Program, Weill Cornell Medical College, New York, NY 10065, USA; Hospital for Special Surgery Research Institute, The David Rosenzweig Genomics Center, New York, NY 10021, USA.

Katharine C Hsu (KC)

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Stefan Jordan (S)

Institute of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Miriam Merad (M)

Marc and Jennifer Lipschultz Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Joseph C Sun (JC)

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Immunology and Microbial Pathogenesis Program, Weill Cornell Medical College, New York, NY 10065, USA. Electronic address: sunj@mskcc.org.

Classifications MeSH